uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Tacquell
Opinion
Human
Details
EMA number
EMEA/H/C/006563
ATC code
L01XL
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of melanoma
MeSH:
Melanoma
Active substances
autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded,
Marketing Authorisation Holder
Netherlands Cancer Institute
MAH
Tacquell | uMedical